LENZ
LENZ Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$12.15
+0.33 ▲ +2.79%
🌙 3월 13일 6:51 PM ET (한국 3/14 07:51)
$12.14
-0.01 ▼ -0.08%
| Index | RUT | P/E | - | EPS (ttm) | -2.11 | Insider Own | 11.75% | Shs Outstand | 0.03B | Perf Week | 4.11% |
| Market Cap | 0.38B | Forward P/E | - | EPS next Y | -15.51% | Insider Trans | -8.86% | Shs Float | 0.03B | Perf Month | -10.07% |
| Enterprise Value | 0.18B | PEG | - | EPS next Q | -0.91 | Inst Own | 104.82% | Short Float | 32.24% | Perf Quarter | -51.48% |
| Income | -0.06B | P/S | 21.72 | EPS this Y | -8.91% | Inst Trans | 16.03% | Short Ratio | 9.03 | Perf Half Y | -70.23% |
| Sales | 0.02B | P/B | 1.79 | EPS next 5Y | 30.84% | ROA | -27.09% | Short Interest | 8.90M | Perf YTD | -24.06% |
| Book/sh | 6.78 | P/C | 1.88 | EPS past 3/5Y | 35.06% -181.63% | ROE | -28.78% | 52W High | -75.89% ($50.40) | Perf Year | -50.91% |
| Cash/sh | 6.46 | P/FCF | - | Sales past 3/5Y | - | ROIC | -30.29% | 52W Low | 8.39% ($11.21) | Perf 3Y | 4.36% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 70.19% | Gross Margin | 98.83% | Volatility(W/M) | 7.6% 7.36% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 10.23 | Sales Y/Y TTM | - | Oper. Margin | -388% | ATR (14) | 1.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.63 | EPS Q/Q | -55.65% | Profit Margin | -336.47% | RSI (14) | 39.13 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.69 | Sales Q/Q | - | SMA20 | -3.19% ($12.55) | Beta | 0.63 | Target Price | $51.29 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -19.12% ($15.02) | Rel Volume | 0.76 | Prev Close | $11.82 |
| Employees | 42 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 14.78% 169.23% | SMA200 | -56.89% ($28.18) | Avg Volume(3M) | 0.99M | Price | $12.15 |
| IPO | 2021/6/25 | Option/Short | Yes/Yes | Trades | 6517 | Volume | 749,907 | Change | 2.79% |
뉴스 로딩 중...